Dirk Mariën

An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

Frank D. Sistare, Daniel Morton, Carl L. Alden et al. · Toxicologic Pathology · 2011 · 152 citations · Full text

Chemoprevention Strategy, Pathology, Toxicology Testing +17

The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension

Nicolas Darville, Marjolein van Heerden, Dirk Mariën et al. · Journal of Controlled Release · 2016 · 62 citations · Full text

Pharmaceutical Science, Pharmacological Study, Angiogenesis Inhibition +8

Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin

Sandra De Jonghe, Jim Proctor, Petra Vinken et al. · Chemico-Biological Interactions · 2014 · 54 citations

Chemoprevention Strategy, Sglt2 Inhibitor Canagliflozin, Oncogenic Agent +6

What have we learned from pre-clinical juvenile toxicity studies?

Graham P. Bailey, Dirk Mariën · Reproductive Toxicology · 2009 · 21 citations

Pediatric Epidemiology, Developmental Toxicology, Toxicology +2

Juvenile animal testing of hydroxypropyl-β-cyclodextrin in support of pediatric drug development

Luc De Schaepdrijver, Dirk Mariën, Cheyma Rhimi et al. · Reproductive Toxicology · 2015 · 13 citations

Pharmaceutical Science, Juvenile Animal Testing, Preclinical Drug Evaluation +9